PoC Capital seeks to invest in small, public life science companies whose product candidates have the opportunity to improve patient well-being. Strong management teams, clear mechanisms of action, and well-validated product development plans are key components of our investment thesis. PoC Capital specifically provides funding for companies to execute proof-of-concept clinical trials, which serve to unlock the value of development-stage assets through safety and efficacy validation.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions